The relationships between XPC binding to conformationally diverse DNA adducts and their excision by the human NER system: Is there a correlation?

Yuan Cho Lee, Yuqin Cai, Hong Mu, Suse Broyde, Shantu Amin, Xuejing Chen, Jung Hyun Min, Nicholas E. Geacintov

Research output: Contribution to journalArticle

Abstract

The first eukaryotic NER factor that recognizes NER substrates is the heterodimeric XPC-RAD23B protein. The currently accepted hypothesis is that this protein recognizes the distortions/destabilization caused by DNA lesions rather than the lesions themselves. The resulting XPC-RAD23B-DNA complexes serve as scaffolds for the recruitment of subsequent NER factors that lead to the excision of the oligonucleotide sequences containing the lesions. Based on several well-known examples of DNA lesions like the UV radiation-induced CPD and 6-4 photodimers, as well as cisplatin-derived intrastrand cross-linked lesions, it is generally believed that the differences in excision activities in human cell extracts is correlated with the binding affinities of XPC-RAD23B to these DNA lesions. However, using electrophoretic mobility shift assays, we have found that XPC-RAD23B binding affinities of certain bulky lesions derived from metabolically activated polycyclic aromatic hydrocarbon compounds such as benzo[. a]pyrene and dibenzo[. a,. l]pyrene, are not directly, or necessarily correlated with NER excision activities observed in cell-free extracts. These findings point to features of XPC-RAD23B-bulky DNA adduct complexes that may involve the formation of NER-productive or unproductive forms of binding that depend on the structural and stereochemical properties of the DNA adducts studied. The pronounced differences in NER cleavage efficiencies observed in cell-free extracts may be due to differences in the successful recruitment of subsequent NER factors by the XPC-RAD23B-DNA adduct complexes, and/or in the verification step. These phenomena appear to depend on the structural and conformational properties of the class of bulky DNA adducts studied.

Original languageEnglish (US)
Pages (from-to)55-63
Number of pages9
JournalDNA Repair
Volume19
DOIs
StatePublished - 2014

Fingerprint

DNA Adducts
Cell Extracts
DNA
Electrophoretic mobility
Benzo(a)pyrene
Polycyclic Aromatic Hydrocarbons
Electrophoretic Mobility Shift Assay
Human Activities
Scaffolds
Oligonucleotides
Ultraviolet radiation
Cisplatin
Assays
Proteins
Cells
Radiation
Substrates

Keywords

  • Benzo[a]pyrene
  • Dibenzo[a,l]pyrene
  • DNA adduct
  • Electrophoretic mobility shift assay
  • Nucleotide excision repair (NER)
  • XPC-RAD23B binding

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology
  • Medicine(all)

Cite this

The relationships between XPC binding to conformationally diverse DNA adducts and their excision by the human NER system : Is there a correlation? / Lee, Yuan Cho; Cai, Yuqin; Mu, Hong; Broyde, Suse; Amin, Shantu; Chen, Xuejing; Min, Jung Hyun; Geacintov, Nicholas E.

In: DNA Repair, Vol. 19, 2014, p. 55-63.

Research output: Contribution to journalArticle

@article{ede95bc815824c5eabd425e155fcbc65,
title = "The relationships between XPC binding to conformationally diverse DNA adducts and their excision by the human NER system: Is there a correlation?",
abstract = "The first eukaryotic NER factor that recognizes NER substrates is the heterodimeric XPC-RAD23B protein. The currently accepted hypothesis is that this protein recognizes the distortions/destabilization caused by DNA lesions rather than the lesions themselves. The resulting XPC-RAD23B-DNA complexes serve as scaffolds for the recruitment of subsequent NER factors that lead to the excision of the oligonucleotide sequences containing the lesions. Based on several well-known examples of DNA lesions like the UV radiation-induced CPD and 6-4 photodimers, as well as cisplatin-derived intrastrand cross-linked lesions, it is generally believed that the differences in excision activities in human cell extracts is correlated with the binding affinities of XPC-RAD23B to these DNA lesions. However, using electrophoretic mobility shift assays, we have found that XPC-RAD23B binding affinities of certain bulky lesions derived from metabolically activated polycyclic aromatic hydrocarbon compounds such as benzo[. a]pyrene and dibenzo[. a,. l]pyrene, are not directly, or necessarily correlated with NER excision activities observed in cell-free extracts. These findings point to features of XPC-RAD23B-bulky DNA adduct complexes that may involve the formation of NER-productive or unproductive forms of binding that depend on the structural and stereochemical properties of the DNA adducts studied. The pronounced differences in NER cleavage efficiencies observed in cell-free extracts may be due to differences in the successful recruitment of subsequent NER factors by the XPC-RAD23B-DNA adduct complexes, and/or in the verification step. These phenomena appear to depend on the structural and conformational properties of the class of bulky DNA adducts studied.",
keywords = "Benzo[a]pyrene, Dibenzo[a,l]pyrene, DNA adduct, Electrophoretic mobility shift assay, Nucleotide excision repair (NER), XPC-RAD23B binding",
author = "Lee, {Yuan Cho} and Yuqin Cai and Hong Mu and Suse Broyde and Shantu Amin and Xuejing Chen and Min, {Jung Hyun} and Geacintov, {Nicholas E.}",
year = "2014",
doi = "10.1016/j.dnarep.2014.03.026",
language = "English (US)",
volume = "19",
pages = "55--63",
journal = "DNA Repair",
issn = "1568-7864",
publisher = "Elsevier",

}

TY - JOUR

T1 - The relationships between XPC binding to conformationally diverse DNA adducts and their excision by the human NER system

T2 - Is there a correlation?

AU - Lee, Yuan Cho

AU - Cai, Yuqin

AU - Mu, Hong

AU - Broyde, Suse

AU - Amin, Shantu

AU - Chen, Xuejing

AU - Min, Jung Hyun

AU - Geacintov, Nicholas E.

PY - 2014

Y1 - 2014

N2 - The first eukaryotic NER factor that recognizes NER substrates is the heterodimeric XPC-RAD23B protein. The currently accepted hypothesis is that this protein recognizes the distortions/destabilization caused by DNA lesions rather than the lesions themselves. The resulting XPC-RAD23B-DNA complexes serve as scaffolds for the recruitment of subsequent NER factors that lead to the excision of the oligonucleotide sequences containing the lesions. Based on several well-known examples of DNA lesions like the UV radiation-induced CPD and 6-4 photodimers, as well as cisplatin-derived intrastrand cross-linked lesions, it is generally believed that the differences in excision activities in human cell extracts is correlated with the binding affinities of XPC-RAD23B to these DNA lesions. However, using electrophoretic mobility shift assays, we have found that XPC-RAD23B binding affinities of certain bulky lesions derived from metabolically activated polycyclic aromatic hydrocarbon compounds such as benzo[. a]pyrene and dibenzo[. a,. l]pyrene, are not directly, or necessarily correlated with NER excision activities observed in cell-free extracts. These findings point to features of XPC-RAD23B-bulky DNA adduct complexes that may involve the formation of NER-productive or unproductive forms of binding that depend on the structural and stereochemical properties of the DNA adducts studied. The pronounced differences in NER cleavage efficiencies observed in cell-free extracts may be due to differences in the successful recruitment of subsequent NER factors by the XPC-RAD23B-DNA adduct complexes, and/or in the verification step. These phenomena appear to depend on the structural and conformational properties of the class of bulky DNA adducts studied.

AB - The first eukaryotic NER factor that recognizes NER substrates is the heterodimeric XPC-RAD23B protein. The currently accepted hypothesis is that this protein recognizes the distortions/destabilization caused by DNA lesions rather than the lesions themselves. The resulting XPC-RAD23B-DNA complexes serve as scaffolds for the recruitment of subsequent NER factors that lead to the excision of the oligonucleotide sequences containing the lesions. Based on several well-known examples of DNA lesions like the UV radiation-induced CPD and 6-4 photodimers, as well as cisplatin-derived intrastrand cross-linked lesions, it is generally believed that the differences in excision activities in human cell extracts is correlated with the binding affinities of XPC-RAD23B to these DNA lesions. However, using electrophoretic mobility shift assays, we have found that XPC-RAD23B binding affinities of certain bulky lesions derived from metabolically activated polycyclic aromatic hydrocarbon compounds such as benzo[. a]pyrene and dibenzo[. a,. l]pyrene, are not directly, or necessarily correlated with NER excision activities observed in cell-free extracts. These findings point to features of XPC-RAD23B-bulky DNA adduct complexes that may involve the formation of NER-productive or unproductive forms of binding that depend on the structural and stereochemical properties of the DNA adducts studied. The pronounced differences in NER cleavage efficiencies observed in cell-free extracts may be due to differences in the successful recruitment of subsequent NER factors by the XPC-RAD23B-DNA adduct complexes, and/or in the verification step. These phenomena appear to depend on the structural and conformational properties of the class of bulky DNA adducts studied.

KW - Benzo[a]pyrene

KW - Dibenzo[a,l]pyrene

KW - DNA adduct

KW - Electrophoretic mobility shift assay

KW - Nucleotide excision repair (NER)

KW - XPC-RAD23B binding

UR - http://www.scopus.com/inward/record.url?scp=84902103235&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902103235&partnerID=8YFLogxK

U2 - 10.1016/j.dnarep.2014.03.026

DO - 10.1016/j.dnarep.2014.03.026

M3 - Article

C2 - 24784728

AN - SCOPUS:84902103235

VL - 19

SP - 55

EP - 63

JO - DNA Repair

JF - DNA Repair

SN - 1568-7864

ER -